ArticleBMJ open2022

Celecoxib versus placebo as an adjunct to treatment-as-usual in children and youth with obsessive-compulsive disorder: protocol for a single-site randomised quadruple-blind phase II study.

Clara Westwell-Roper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.